Economic evaluations of influenza vaccination in healthy working-age adults: Employer and society perspective

PharmacoEconomics

Volumn 18, Issue 2, 2000, Pages 173-183

  Wood, S C ^a   Nguyen, V H ^a   Schmidt, C ^b  

^a SANOFI PASTEUR   (France)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ARTICLE; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; ECONOMIC EVALUATION; EMPLOYEE; EMPLOYER; HEALTH CARE COST; HUMAN; INFLUENZA; INFLUENZA VACCINATION; PRIORITY JOURNAL; SIMULATION; WORK CAPACITY;

EID: 0033899361     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-200018020-00007     Document Type: Article

References (29)

1. Acute viral infection of upper respiratory tract in elderly people living in the community: Comparative prospective population-based study of disease burden
2. Impact of epidemic type A influenza in a defined adult population
3. The influenza herald wave
4. Global impact of influenza on morbidity and mortality
5. Estimate of the US health impact of influenza
6. Influenza vaccination: Cost-effectiveness and public policy
7. Economic impact of influenza: The individual's perspective
8. The economic impact of pandemic influenza in the United States: Priorities for intervention
9. Prevention and early treatment of influenza in healthy adults
10. Evaluating the impact of influenza vaccination: A North American perspective
11. Influenza vaccination in 29 countries: An update to 1997
12. Cost-effectiveness and cost-benefit analyses in the medical literature: Are the methods being used correctly?
13. Effectiveness and cost-benefit of an influenza vaccination program for healthcare workers
14. La vaccination contre la grippe des personnes d'age actif (24-64 ans): Une etude cout-benefice
15. French economic evaluations of influenza and influenza vaccination
16. The effectiveness of vaccination against influenza in healthy, working adults
17. Influenza vaccination among healthy employees: A cost-benefit analysis
18. Cost-effectiveness of the influenza vaccine in a healthy, working-age population
19. Economic impact of providing influenza workplace influenza vaccination
20. Assigning money values to health outcomes
21. New vaccine development: Establishing priorities
22. Side effects associated with influenza vaccination in healthy working adults: A randomised placebo-controlled trial
23. Influenza vaccination of healthcare workers in long-term care hospitals reduces the mortality of elderly patients
24. Effects of influenza vaccination of healthcare workers on mortality of elderly people in long-term care: A randomised controlled trial
25. Socioeconomics of influenza vaccination in Europe
26. An exercise on the feasibility of carrying out secondary economic analyses